4/A//SEC Filing
ENDRA Life Sciences Inc. 4/A
Accession 0001209191-17-034737
$NDRACIK 0001681682operating
Filed
May 22, 8:00 PM ET
Accepted
May 23, 6:05 PM ET
Size
8.0 KB
Accession
0001209191-17-034737
Insider Transaction Report
Form 4/AAmended
Tokman Alexander Y
DirectorChief Executive Officer
Transactions
- Award
Stock Options
2017-05-12+6,000→ 6,000 totalExercise: $5.00From: 2017-05-12Exp: 2025-05-12→ Common Stock (6,000 underlying) - Award
Stock Options
2017-05-12+6,000→ 6,000 totalExercise: $5.00From: 2017-12-31Exp: 2025-05-12→ Common Stock (6,000 underlying)
Footnotes (2)
- [F1]This amendment is being filed to correct the expiration date of these Stock Options, which was inadvertantly reported as May 12, 2022. The correct expiration date is May 12, 2025.
- [F2]This amendment is being filed to correct the exercisable date of these Stock Options, which was inadvertantly reported as May 12, 2017. The correct exercisable date is December 31, 2017.
Documents
Issuer
ENDRA Life Sciences Inc.
CIK 0001681682
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001681682
Filing Metadata
- Form type
- 4/A
- Filed
- May 22, 8:00 PM ET
- Accepted
- May 23, 6:05 PM ET
- Size
- 8.0 KB